We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Systems Market to Reach USD 11.72 Billion by 2025

By HospiMedica International staff writers
Posted on 18 May 2019
The global Magnetic Resonance Imaging (MRI) systems market is expected to grow at a CAGR of 6.4% between 2018 and 2025 to reach USD 11.72 billion by 2025, driven by increased healthcare spending and sophisticated healthcare infrastructure in the developed nations, as well as recent technological advancements.

These are the latest findings of Fortune Business Insights (Pune, Maharashtra, India), a provider of expert corporate analysis and accurate data.

Based on strength, 1.5 T MRI systems dominated the global MRI systems market in 2017 with the largest share of 70.5%. More...
There is high demand for 1.5 T MRI systems in the emerging as well as developed nations as these systems offer higher value for money. Additionally, increasing willingness to spend on advanced healthcare and the presence of a sophisticated healthcare infrastructure in the developed nations will also fuel the demand for advanced MRI systems.

The global MRI systems market is also expected to benefit from recent technological advancements. The growing demand for improved accuracy in diagnostic imaging has created scope for the development of specialized MRI systems, such as neonatal MRI systems and breast MRI systems, among others. However, the cost of an MRI system is directly proportional to its in-built technology, thus posing a challenge to the market growth.

Buyers face the key challenge of managing the increasing pricing pressures of acquiring and maintaining an advanced MRI system. Moreover, stringent regulatory approvals and intensifying competition from Computed Tomography (CT) systems could create bottlenecks to growth for companies in the MRI systems market.

Geographically, Asia Pacific dominated the global MRI systems market in 2017 with the highest value of USD 3.15 billion and is expected to maintain its leading position during the forecast period. The Asia Pacific MRI systems market is likely to be driven by the leading players penetrating deeper into the emerging nations, increasing patient pool, and rising prevalence of neurological and musculoskeletal disorders in the region.

The North American and European MRI systems market is expected to witness lucrative growth prospects due to the increasing adoption of advanced MRI systems with more than 1.5 T strength in these regions. On the other hand, the growth of the MRI systems market in the Middle East and Africa will be led by collaborations between US-based healthcare institutions and domestic healthcare organizations.

Related Links:
Fortune Business Insights


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Glucose Meter
StatStrip®
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.